Table 6
Results of comparisons of glioma patient groups and control groups
| One way ANOVA | Kruskall-Wallis ANOVA | |
|---|---|---|
| Bonferroni post hoc tests (p<0.006): *worse scores in the glioma groups I, II, III, and IV, and chronic disease group v healthy subjects; †worse scores in the glioma groups I and II, and chronic disease group v healthy subjects. Mann-Whitney post hoc tests (p<0.006): ‡worse scores in the glioma groups I, II, III, and IV, and chronic disease group v healthy subjects; §worse scores in the glioma group II v chronic disease group. | ||
| ADL, Activity Daily Living; AM, Attentive Matrices; FLIC, Functional Living Index—Cancer; KPS, Karnofsky Performance Status; RCPM, Raven’s Coloured Progressive Matrices; SR, Story Recall; SRDS, Self Rating Depression Scale; STAI1/2, State Trait Anxiety Inventory 1/2; TMTA/B, Trail Making Test A/B. | ||
| FLIC total score | NS | NS |
| STAI1 | F(5,160) = 19.49; p<0.0001* | |
| STAI2 | F(5,160) = 10.46; p<0.0001* | |
| SRDS | F(5,160) = 10.21; p<0.0001† | |
| SR | F(5,160) = 14.27; p<0.0001* | |
| RCPM | χ2 = 46,19; p<0.0001‡ | |
| AM | χ2 = 77.37; p<0.0001‡§ | |
| TMTA | χ2 = 67.43; p<0.0001‡ | |
| TMTB | χ2 = 58.05; p<0.0001‡ | |
